The purpose of this study is to determine the response rate and overall survival in patients that have been diagnosed with mesothelioma and will undergo chemotherapy, surgery and intensity modified radiation therapy (IMRT) as part of their standard of care.
|First Received Date||November 20, 2015|
|Last Changed Date||January 5, 2018|
|Start Date||March 18, 2016|
|Anticipated Primary Completion Date||December 2018|
|Primary Outcome Measures||
Survival status upon review of patients every 6 months [Time Frame: 2 years]
|Secondary Outcome Measures||
Progression free survival as evidenced by CT scan review [Time Frame: 2 years]
|Study Arms / Comparison Groups||0 / 1|
The investigators will consent patients that have been diagnosed with mesothelioma and will undergo chemotherapy followed by surgery and then IMRT as their standard of care. The investigators will collect data from past and future medical records as well as data regarding their health status for their lifetime by reviewing life status, treatment status and CT scans.
|Ages||18 Years - N/A|
|Accepts Healthy Volunteers||No|
Karlyn Pierson, RN
- Subject provides informed consent
- Subject is >18 years of age
- Subject is deemed competent for making medical decisions
- Subject is scheduled to undergo chemotherapy followed by surgery and then IMRT
- Subject is a surgical candidate
- A negative pregnancy test is required in women of child-bearing potential, as standard of care.
•Subject is <18 years old.
|Responsible Party||Principal Investigator|
|Verification Date||January 2018|